Prostate cancer vaccines, including dendritic and peptide types, offer hope for improved treatments, but face hurdles in ...

Therapeutic mRNAs offer great potential as a versatile and precise tool against cancer and other diseases. However, the ...

Dr Koski reported contract work for the CTL Corporation and a patent pending for dendritic cell production and activation ...

The global Hematopoietic Stem Cell Transplantation Market is worth USD 7 Billion as of now and expected to reach USD 15 ...

Therapeutic mRNAs offer great potential as a versatile and precise tool against cancer and various other diseases. However, the therapeutic effectiveness is limited by the poor translation uptake of ...

Dr. Damya Laoui (VIB-VUB): "It is great to see that our strategy to use LNPs to administer therapeutic mRNAs into the tumor, works. It stimulates the immune system to recognize and eliminate cancer ...

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing ...

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the Company") presented a new study today at ...

The TIME is a dynamic network composed of cancer cells, immune cells, and stromal components. During the early stages of tumorigenesis, the TIME ...

Among these sensors, we further focused on the spatiotemporal dynamics of Rab10 and Rab4 activity during sLTP. We found that postsynaptic stimulation leads to the persistent inactivation of Rab10 and ...

Interaction between genetic factors, estrogen and aging in the development of Th1/TH2 differentiation and subsequent autoimmune diseases in aging women. DC: Dendritic cell; Th: T-helper cell.